Navigation Links
Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
Date:10/13/2011

ST. LOUIS, Oct. 13, 2011 /PRNewswire/ -- CuraScript, Inc., a wholly owned subsidiary of Express Scripts, Inc., is now the exclusive specialty pharmacy for patients using Solesta®, a product of Oceana Therapeutics Inc., under an agreement announced today. Part of Express Scripts HealthBridge Pharma & Biotech services, CuraScript SD Specialty Distribution will be one of two national distributors responsible for delivering Solesta to healthcare providers.

Solesta is the only nonsurgical treatment approved by the Food and Drug Administration for patients who fail conservative therapy for fecal (bowel) incontinence. A biocompatible tissue-bulking agent, Solesta is an injectable gel administered in an outpatient setting without the need for anesthesia. Oceana Therapeutics has exclusive rights to market, sell and distribute Solesta, a registered trademark of the international medical device company Q-Med AB.

About HealthBridge Pharma & BiotechHealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs (PAP), data and sales reporting, enhanced account services, and customized adherence programs.

As a service of HealthBridge Pharma & Biotech, CuraScript SP Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma/Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.

CuraScript SD Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions for physicians' offices, practices, surgery centers, hospitals and other clinical settings.

More information can be found at http://TheHealthBridgeSolution.com/.

About Express ScriptsExpress Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/. Media Contact:

Thom Gross314.684.6321rtgross@express-scripts.com
'/>"/>

SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts Announces Revised 2011 Financial Guidance
2. ChemoMetec and De Novo Software to Co-market NucleoCounter® NC-3000™ and FCS Express 4 Image Cytometry Software
3. Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens
4. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
5. Molecular Devices Announces ImageXpress Micro XL High-Content Screening System
6. Express Scripts to Present at Investor Conferences in September
7. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
8. Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
9. Express Scripts Announces Second Quarter 2011 Earnings Conference Call
10. Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
11. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... national conference convening academic faculty engaged in or interested in palliative care education and ... will be held in North County San Diego on Sept. 28 and 29, ...
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... official 2017 partnership with The Jensie Gran Fondo of Marin. For the second ... rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
Breaking Medicine News(10 mins):